Purification of the recombinant human serotonin N-acetyltransferase (EC 2.3.1.87):: further characterization of and comparison with AANAT from other species

被引:14
作者
Ferry, G
Ubeaud, C
Dauly, C
Mozo, J
Guillard, S
Berger, S
Jimenez, S
Scoul, C
Leclerc, G
Yous, S
Delagrange, P
Boutin, JA
机构
[1] Inst Rech Servier, F-78290 Croissy Sur Seine, France
[2] Fac Sci Pharmaceut & Biol Lille, Chim Therapeut Lab, F-59000 Lille, France
[3] Inst Rech Servier, F-92150 Suresnes, France
关键词
melatonin; serotonin N-acetyltransferase; Ni-NTA chromatography; denaturation-renaturation process; purification; inhibitors; substrates; rat; ovine; human; GroEL;
D O I
10.1016/j.pep.2004.07.004
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Melatonin is synthesized by a series of enzymes, the penultimate one, serotonin N-acetyltransferase, catalyzing the limiting reaction. In the present study, we compared the recombinant serotonin N-acetyltransferases from rat, ovine, and human. The human protein is particularly difficult to purify because it interacts strongly with a putative chaperone protein from bacteria whereas the rat and sheep enzymes, which interact less strongly with this protein, have been purified close to homogeneity. We identified the contaminating protein as GroEL, the bacterial equivalent of Hsp60. We present numerous catalytic activities (substrate and cosubstrate specificities as well as inhibitor specificities) measured on the three species enzymes from which we deduced that the presence of the chaperone might partly explain the differences between the various species enzyme characteristics, beside the inter-species ones resulting from sequence differences. Despite several trials reported in the literature, a purification to homogeneity of the human (recombinant) enzyme has never been described. We present a new purification method, by using an original denaturation/renaturation process in which the enzyme is immobilized on an affinity chromatography column. The enzyme is then eluted in an active and pure form (i.e., absence of chaperone). The up-scaled system permitted us to perform the necessary experiments for the measurement of more accurate affinities of human serotonin N-acetyltransferase towards its main natural substrates, showing that only the activity of the enzyme towards phenylethylamine was modified. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:84 / 98
页数:15
相关论文
共 56 条
[11]   Two arylalkylamine N-acetyltransferase genes mediate melatonin synthesis in fish [J].
Coon, SL ;
Bégay, V ;
Deurloo, D ;
Falcón, J ;
Klein, DC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (13) :9076-9082
[12]   cAMP regulation of arylalkylamine N-acetyltransferase (AANAT, EC 2.3.1.87) -: A new cell line (1E7) provides evidence of intracellular AANAT activation [J].
Coon, SL ;
Weller, JL ;
Korf, HW ;
Namboodiri, MAA ;
Rollag, M ;
Klein, DC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (26) :24097-24107
[13]   Identification of specific histidine residues and the carboxyl terminus are essential for serotonin N-acetyltransferase enzymatic activity [J].
Craft, CM ;
Zhan-Poe, X .
MOLECULAR BRAIN RESEARCH, 2000, 75 (02) :198-207
[14]   Peroxisome proliferator-activated receptor γ (PPARγ) as a molecular target for the soy phytoestrogen genistein [J].
Dang, ZC ;
Audinot, V ;
Papapoulos, SE ;
Boutin, JA ;
Löwik, CWGM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (02) :962-967
[15]   Kinetic analysis of the catalytic mechanism of serotonin N-acetyltransferase (EC 2.3.1.87) [J].
De Angelis, J ;
Gastel, J ;
Klein, DC ;
Cole, PA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (05) :3045-3050
[16]   Melatonin, its receptors, and relationships with biological rhythm disorders [J].
Delagrange, P ;
GuardiolaLemaitre, B .
CLINICAL NEUROPHARMACOLOGY, 1997, 20 (06) :482-510
[17]   Therapeutic perspectives for melatonin agonists and antagonists [J].
Delagrange, P ;
Atkinson, J ;
Boutin, JA ;
Casteilla, L ;
Lesieur, D ;
Misslin, R ;
Pellissier, S ;
Pénicaud, L ;
Renard, P .
JOURNAL OF NEUROENDOCRINOLOGY, 2003, 15 (04) :442-448
[18]   Evidence for consistent patterns between flavonoid structures and cellular activities [J].
Depeint, F ;
Gee, JM ;
Williamson, G ;
Johnson, IT .
PROCEEDINGS OF THE NUTRITION SOCIETY, 2002, 61 (01) :97-103
[19]   High-capacity screening of arylalkylamine N-acetyltransferase inhibitors using a high-performance liquid chromatography system [J].
Ferry, G ;
Boutin, JA .
JOURNAL OF BIOMOLECULAR SCREENING, 2000, 5 (05) :361-368
[20]   Substrate specificity and inhibition studies of human serotonin N-acetyltransferase [J].
Ferry, G ;
Loynel, AM ;
Kucharczyk, N ;
Bertin, S ;
Rodriguez, M ;
Delagrange, P ;
Galizzi, JP ;
Jacoby, E ;
Volland, JP ;
Lesieur, D ;
Renard, P ;
Canet, E ;
Fauchère, JL ;
Boutin, JA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (12) :8794-8805